Nelson Advisors LLP: Profile of a European Healthcare Technology M&A Specialist

Nelson Advisors
3 minutes ago
7 min read

I. Executive Summary: Navigating the "Nelson" Landscape

Nelson Advisors LLP, a UK-based firm, is explicitly and exclusively focused on providing mergers and acquisitions (M&A) advisory services within the healthcare technology sector across the United Kingdom, Europe, and North America. The firm’s core value proposition is rooted in a distinctive "practitioner-led" approach. This model is a direct function of the synergistic partnership between its two co-founders, whose professional backgrounds combine extensive corporate finance expertise with direct, hands-on experience in building, scaling, and successfully exiting healthcare technology businesses.

Nelson Advisors LLP

A. Core Business and Specialisation

Nelson Advisors LLP positions itself as a specialised M&A advisory firm with an exclusive dedication to the dynamic healthcare technology (HealthTech) sector. Its core focus encompasses a range of sub sectors, including MedTech, Digital Health, Health IT, Consumer HealthTech, Healthcare Cybersecurity, and Healthcare AI companies.

The firm’s geographic scope is explicitly stated to cover the UK, Europe, and North America, indicating a transatlantic reach for its specialised services. This concentration on a single, high-growth vertical allows the firm to cultivate a deep level of industry-specific knowledge and a network that generalist M&A firms typically cannot match.

B. Business Model and Service Offerings

The firm's business model is a direct reflection of its founders' practitioner-led approach. They frame their advisory services around a "Build, Buy, Partner, Sell" framework, a model born from their personal experience in the industry. The firm provides a comprehensive suite of M&A services, including buy-side and sell-side advisory, corporate divestitures, and roll-up strategies.

These transaction-focused services are complemented by strategic advisory offerings, such as go-to-market strategies and international expansion guidance. The average client engagement is noted to last between three and six months, suggesting a business model centred on specific, time-bound, and project-based transactions rather than long-term, retainer-based advisory.This structure indicates an optimisation for a streamlined, project-oriented revenue stream.

C. Official Corporate Information

Nelson Advisors LLP is a newly established entity with a recent incorporation date. It was formed as an active limited liability partnership (LLP) on April 7, 2025, a crucial detail for any party conducting due diligence. The firm's official company number is OC456267, and its registered office address is Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT.

Official Corporate Details of Nelson Advisors LLP

Data Point	Detail
Official Name	NELSON ADVISORS LLP
Company Number	OC456267
Corporate Status	Active Limited Liability Partnership
Date of Incorporation	April 7, 2025
Registered Address	76-78 Portland Place, London, United Kingdom, W1B 1NT

Leadership and Foundational Expertise: The Practitioner-Led Advantage

The primary asset of Nelson Advisors LLP is the combined and synergistic experience of its two co-founders, Lloyd Price and Paul Hemings. Their backgrounds are distinct yet complementary, creating a unique advisory offering for the HealthTech market.

A. The Founding Partners: Lloyd Price and Paul Hemings

Lloyd Price is a co-founder with a strong background in technology entrepreneurship and strategic business development. His career includes senior roles at major internet companies such as Yahoo! Europe and Badoo/Bumble from 2000 to 2012.

His most significant achievement is the founding and successful exit of Zesty, a HealthTech business that was acquired by Induction Healthcare Group PLC in 2020. Beyond his entrepreneurial ventures, he serves as a Non-Executive Director for various UK digital health companies, mentors students, and regularly guest lectures at prestigious university business schools like University College London, Oxford University, and Cambridge University.

He is a founding member of the "Digital Healthcare Council" and has served as a judge for industry awards, including the Digital Health Pitchfest Awards. His experience provides the firm with deep operational and strategic insight into the lifecycle of a HealthTech company.

Paul Hemings, the other co-founder, brings a decade of global M&A and capital-raising expertise. His corporate finance career includes senior investment banking advisory roles at Credit Suisse, where he advised on over $50 billion in M&A transactions and over $40 billion in equity/financing deals across numerous countries.

He also possesses his own entrepreneurial experience, having founded and exited two early-stage companies. His educational background includes an honours degree in Economics from Queen's University and an MBA from London Business School. Hemings’s profile provides the institutional rigor and financial acumen necessary to navigate complex corporate transactions and effectively engage with institutional investors and large corporate acquirers.

B. A Synergistic Partnership and Unique Value Proposition

The combined professional history of Price and Hemings forms the foundation of the firm's practitioner-led advantage. Together, they have built, scaled, and exited four HealthTech businesses since 2012, in sectors ranging from patient engagement to medical device cybersecurity.

The synergy between their skill sets is a key differentiator. Hemings provides the classic, institutional-grade M&A expertise that is essential for structuring complex deals, while Price brings the hands-on operational reality and strategic market insight of a successful founder.

This fusion allows the firm to effectively "bridge the gap between innovative HealthTech startups and the demands of institutional investors and large corporate acquirers". The firm's ability to provide guidance that is not only financially sound but also operationally and strategically informed is a direct consequence of its founders' dual expertise.

Market Position, Thought Leadership

Nelson Advisors LLP is as a leading authority in the European HealthTech M&A landscape through a combination of focused expertise and public engagement.

A. Industry Engagement and Thought Leadership

The firm maintains a robust content strategy to demonstrate its deep market knowledge. Its blog features a range of specialised articles on topics such as "HealthTech Mergers & Acquisitions" and "Partnerships & Investments".

Recent blog posts include in-depth analyses of trends like "Digital MSK Europe" and "The European HealthTech M&A Landscape," as well as research on "HealthTech M&A valuation multiples" and fundraising processes for early-stage companies. This content directly signals the firm's hyper-specialisation and its commitment to providing valuable market intelligence.

The founders’ external engagements such as guest lecturing at prominent business schools and serving as judges for industry awards, further solidify their standing as respected thought leaders within the European HealthTech community.

Analysis of Thought Leadership and Industry Credibility

Activity	Description
Blog & Market Research	Publishes articles and market reports on HealthTech M&A, valuations, and industry trends.
Awards Judging	Co-founder Lloyd Price has served as a judge for the Digital Health Pitchfest Awards (2022, 2023) and the HealthInvestor Awards (2024, 2025).
Guest Speaking	Both founders regularly guest lecture and speak at leading business schools, including UCL, Oxford, Cambridge, and London Business School.
Industry Networks	Co-founder Lloyd Price founded "The Future Health community" and was a founding member of the "Digital Healthcare Council".

Conclusion: Distinctive and credible advisory firm

Nelson Advisors LLP is a distinctive and credible advisory firm that stands apart from the multitude of unrelated entities sharing its name. The firm's value is not derived from a long corporate history under its current name but is instead inextricably linked to the extensive and synergistic experience of its founding partners, Lloyd Price and Paul Hemings.

By combining hands-on entrepreneurial experience with institutional-grade corporate finance expertise, the firm offers a highly specialised, practitioner-led advisory service tailored to the unique complexities of the healthcare technology sector.

While the firm’s recent incorporation date means its corporate track record is short, the founders’ individual track records provide a strong foundation for its credibility. For a company or investor operating in the HealthTech and MedTech space, this specialised approach and leadership pedigree are compelling assets.

The firm's proactive self-differentiation and robust thought leadership further demonstrate its strategic positioning.

As a result, Nelson Advisors LLP emerges as a highly credible partner for those seeking an advisory firm that possesses not only a nuanced understanding of financial mechanics but also the strategic and operational acumen to navigate the full lifecycle of a healthcare technology business.

Nelson Advisors > HealthTech and MedTech M&A

Nelson Advisors specialise in mergers and acquisitions, partnerships and investments for MedTech, Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish MedTech and Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

We share our views with MedTech and Healthcare Technology insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Founders for Founders > We pride ourselves on our DNA as ‘HealthTech founders advising HealthTech and MedTech founders.’ Nelson Advisors partner with entrepreneurs, chair persons, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #MedTech #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #BuySide #SellSide #DefenceTech #Nelson #Advisors